Drug Shortage Report for APO-SUCRALFATE - TAB 1G
Report ID | 169045 |
Drug Identification Number | 02125250 |
Brand name | APO-SUCRALFATE - TAB 1G |
Common or Proper name | SUCRALFATE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | SUCRALFATE |
Strength(s) | 1G |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | A02BX |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-09-06 |
Estimated end date | 2023-09-22 |
Actual end date | 2023-09-15 |
Shortage status | Resolved |
Updated date | 2023-09-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v40 | 2023-09-22 | French | Compare |
v39 | 2023-09-22 | English | Compare |
v38 | 2023-09-15 | French | Compare |
v37 | 2023-09-15 | English | Compare |
v36 | 2023-09-01 | French | Compare |
v35 | 2023-09-01 | English | Compare |
v34 | 2023-08-23 | French | Compare |
v33 | 2023-08-23 | English | Compare |
v32 | 2023-07-13 | French | Compare |
v31 | 2023-07-13 | English | Compare |
v30 | 2023-06-16 | French | Compare |
v29 | 2023-06-16 | English | Compare |
v28 | 2023-06-09 | French | Compare |
v27 | 2023-06-09 | English | Compare |
v26 | 2023-05-12 | French | Compare |
v25 | 2023-05-12 | English | Compare |
v24 | 2023-04-21 | French | Compare |
v23 | 2023-04-21 | English | Compare |
v22 | 2023-03-23 | French | Compare |
v21 | 2023-03-23 | English | Compare |